Maximal Testosterone Suppression in Prostate Cancer-Free vs Total Testosterone
Rove, Kyle O; Crawford, E David; Perachino, Massimo; Morote, Juan; Klotz, Laurence; Lange, Paul H; Andriole, Gerald L; Matsumoto, Alvin M; Taneja, Samir S; Eisenberger, Mario A; Reis, Leonardo O
Testosterone remains a key target in the treatment of advanced prostate cancer. The relationship of free testosterone to prostate cancer treatment and outcomes remains largely unexplored. A consensus of prostate cancer experts was convened in 2013 to review current knowledge surrounding relationship of total and free testosterone to prostate cancer, discuss the free hormone hypothesis, and highlight future avenues for therapeutics. Free testosterone may better reflect prostate cancer tissue androgen levels than serum total testosterone concentration. Free testosterone deserves more research regarding its relation to clinical outcomes.
PMCID:4332796
PMID: 24713136
ISSN: 0090-4295
CID: 952022
Optimization of Prostate Biopsy: Review of Technique and Complications
Bjurlin, Marc A; Wysock, James S; Taneja, Samir S
A 12-core systematic biopsy that incorporates apical and far-lateral cores in the template distribution allows maximal cancer detection and avoidance of a repeat biopsy while minimizing the detection of insignificant prostate cancers. Magnetic resonance imaging-guided prostate biopsy has an evolving role in both initial and repeat prostate biopsy strategies, potentially improving sampling efficiency, increasing the detection of clinically significant cancers, and reducing the detection of insignificant cancers. Hematuria, hematospermia, and rectal bleeding are common complications of prostate needle biopsy, but are generally self-limiting and well tolerated. All men should receive antimicrobial prophylaxis before biopsy.
PMCID:4151475
PMID: 24725491
ISSN: 0094-0143
CID: 914772